Pernille Tine Jensen

New insights into early recovery after robotic surgery for endometrial cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

New insights into early recovery after robotic surgery for endometrial cancer. / Jørgensen, S L; Mogensen, O; Petersen, M A; Wu, C S; Jensen, P T.

I: Gynecologic Oncology, Bind 153, Nr. 2, 05.2019, s. 271-276.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Jørgensen, SL, Mogensen, O, Petersen, MA, Wu, CS & Jensen, PT 2019, 'New insights into early recovery after robotic surgery for endometrial cancer', Gynecologic Oncology, bind 153, nr. 2, s. 271-276. https://doi.org/10.1016/j.ygyno.2019.02.006

APA

CBE

MLA

Vancouver

Author

Jørgensen, S L ; Mogensen, O ; Petersen, M A ; Wu, C S ; Jensen, P T. / New insights into early recovery after robotic surgery for endometrial cancer. I: Gynecologic Oncology. 2019 ; Bind 153, Nr. 2. s. 271-276.

Bibtex

@article{99940ef5b2e94d24843ca65235e8cec3,
title = "New insights into early recovery after robotic surgery for endometrial cancer",
abstract = "OBJECTIVE: To assess early recovery of physical health after robotic minimally invasive surgery (RMIS) for early-stage endometrial cancer using the European Organisation of Research and Treatment of Cancer Computer Adaptive Test Core questionnaire (EORTC CAT Core). The EORTC CAT Core provides individualised measurements while maintaining comparability. A hypothesis of individual complete recovery to baseline within three post-surgical weeks was evaluated.METHODS: Ninety-four women who underwent RMIS for early-stage endometrial cancer were included consecutively. The EORTC CAT Core was distributed before surgery and prospectively every week during the first post-operative month. Repeated measures models were fitted for each of the four domains (physical functioning, role function, fatigue, and pain) and tested for impact of age, ASA score, minor/major surgery, and the individual baseline scores (poorest, intermediate, best).RESULTS: Women with the lowest physical functioning, lowest role function, highest fatigue level, and highest pain level at baseline all recovered within three weeks. Women with the highest physical functioning, highest role function, lowest level of fatigue, and lowest level of pain at baseline did not reach their individual baselines within the first post-operative month but had the most favourable domain-scores three weeks post-operatively.CONCLUSION: The individual woman's physical health baseline score is predictive for her postoperative recovery following RMIS for early-stage endometrial cancer. Women with the best physical health had the best postoperative functions and lowest level of symptoms; however their recovery to baseline was prolonged. Computer adaptive testing may be a valuable tool for individualised pre-operative information and supportive care during surveillance.",
keywords = "Aged, Endometrial Neoplasms/surgery, Female, Humans, Hysterectomy/adverse effects, Middle Aged, Postoperative Care/methods, Postoperative Period, Quality of Life, Robotic Surgical Procedures/adverse effects, Salpingo-oophorectomy/adverse effects, Time Factors, Treatment Outcome",
author = "J{\o}rgensen, {S L} and O Mogensen and Petersen, {M A} and Wu, {C S} and Jensen, {P T}",
note = "Copyright {\textcopyright} 2019. Published by Elsevier Inc.",
year = "2019",
month = may,
doi = "10.1016/j.ygyno.2019.02.006",
language = "English",
volume = "153",
pages = "271--276",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press",
number = "2",

}

RIS

TY - JOUR

T1 - New insights into early recovery after robotic surgery for endometrial cancer

AU - Jørgensen, S L

AU - Mogensen, O

AU - Petersen, M A

AU - Wu, C S

AU - Jensen, P T

N1 - Copyright © 2019. Published by Elsevier Inc.

PY - 2019/5

Y1 - 2019/5

N2 - OBJECTIVE: To assess early recovery of physical health after robotic minimally invasive surgery (RMIS) for early-stage endometrial cancer using the European Organisation of Research and Treatment of Cancer Computer Adaptive Test Core questionnaire (EORTC CAT Core). The EORTC CAT Core provides individualised measurements while maintaining comparability. A hypothesis of individual complete recovery to baseline within three post-surgical weeks was evaluated.METHODS: Ninety-four women who underwent RMIS for early-stage endometrial cancer were included consecutively. The EORTC CAT Core was distributed before surgery and prospectively every week during the first post-operative month. Repeated measures models were fitted for each of the four domains (physical functioning, role function, fatigue, and pain) and tested for impact of age, ASA score, minor/major surgery, and the individual baseline scores (poorest, intermediate, best).RESULTS: Women with the lowest physical functioning, lowest role function, highest fatigue level, and highest pain level at baseline all recovered within three weeks. Women with the highest physical functioning, highest role function, lowest level of fatigue, and lowest level of pain at baseline did not reach their individual baselines within the first post-operative month but had the most favourable domain-scores three weeks post-operatively.CONCLUSION: The individual woman's physical health baseline score is predictive for her postoperative recovery following RMIS for early-stage endometrial cancer. Women with the best physical health had the best postoperative functions and lowest level of symptoms; however their recovery to baseline was prolonged. Computer adaptive testing may be a valuable tool for individualised pre-operative information and supportive care during surveillance.

AB - OBJECTIVE: To assess early recovery of physical health after robotic minimally invasive surgery (RMIS) for early-stage endometrial cancer using the European Organisation of Research and Treatment of Cancer Computer Adaptive Test Core questionnaire (EORTC CAT Core). The EORTC CAT Core provides individualised measurements while maintaining comparability. A hypothesis of individual complete recovery to baseline within three post-surgical weeks was evaluated.METHODS: Ninety-four women who underwent RMIS for early-stage endometrial cancer were included consecutively. The EORTC CAT Core was distributed before surgery and prospectively every week during the first post-operative month. Repeated measures models were fitted for each of the four domains (physical functioning, role function, fatigue, and pain) and tested for impact of age, ASA score, minor/major surgery, and the individual baseline scores (poorest, intermediate, best).RESULTS: Women with the lowest physical functioning, lowest role function, highest fatigue level, and highest pain level at baseline all recovered within three weeks. Women with the highest physical functioning, highest role function, lowest level of fatigue, and lowest level of pain at baseline did not reach their individual baselines within the first post-operative month but had the most favourable domain-scores three weeks post-operatively.CONCLUSION: The individual woman's physical health baseline score is predictive for her postoperative recovery following RMIS for early-stage endometrial cancer. Women with the best physical health had the best postoperative functions and lowest level of symptoms; however their recovery to baseline was prolonged. Computer adaptive testing may be a valuable tool for individualised pre-operative information and supportive care during surveillance.

KW - Aged

KW - Endometrial Neoplasms/surgery

KW - Female

KW - Humans

KW - Hysterectomy/adverse effects

KW - Middle Aged

KW - Postoperative Care/methods

KW - Postoperative Period

KW - Quality of Life

KW - Robotic Surgical Procedures/adverse effects

KW - Salpingo-oophorectomy/adverse effects

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1016/j.ygyno.2019.02.006

DO - 10.1016/j.ygyno.2019.02.006

M3 - Journal article

C2 - 30808516

VL - 153

SP - 271

EP - 276

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -